IRON ▲ +0.2% - Disc Medicine, Inc.
$IRON - Disc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)
18-OCT-2026 05:00 PM ET
Share this post
More filings for $IRON
IRON ▼ -0.1% - Disc Medicine, Inc.Sep 9, 2026IRON ▼ -1.7% - Disc Medicine, Inc.Aug 31, 2026IRON - Disc Medicine, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $IRON filing history →💬 Comments
Loading comments…
Leave a comment